456
Participants
Start Date
February 28, 2010
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
insulin degludec
Injected s.c. (under the skin) once daily. Dose was individually adjusted.
insulin detemir
Injected s.c. (under the skin) once daily or twice daily (BID). Dose was individually adjusted.
insulin aspart
Injected s.c. (under the skin) as mealtime insulin. Dose was individually adjusted.
Novo Nordisk Investigational Site, Skopje
Novo Nordisk Investigational Site, Rosario
Novo Nordisk Investigational Site, Torino
Novo Nordisk Investigational Site, Hämeenlinna
Novo Nordisk Investigational Site, Lahti
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Treviglio
Novo Nordisk Investigational Site, Treviso
Novo Nordisk Investigational Site, Tampere
Novo Nordisk Investigational Site, Forlì
Novo Nordisk Investigational Site, Seinäjoki
Novo Nordisk Investigational Site, Bari
Novo Nordisk Investigational Site, Kuopio
Novo Nordisk Investigational Site, Partinico
Novo Nordisk Investigational Site, Palermo
Novo Nordisk Investigational Site, Gazi
Novo Nordisk Investigational Site, New Dehli
Novo Nordisk Investigational Site, Milan
Novo Nordisk Investigational Site, Ahmedabad
Novo Nordisk Investigational Site, Ramdaspeth / Nagpur
Novo Nordisk Investigational Site, Dhantoli, Nagpur
Novo Nordisk Investigational Site, Bilāspur
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Caba
Novo Nordisk Investigational Site, Ciudad Autónoma de Bs As
Novo Nordisk Investigational Site, Mar del Plata
Novo Nordisk Investigational Site, Porto Alegre
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, Marília
Novo Nordisk Investigational Site, Porto Alegre
Novo Nordisk Investigational Site, São Paulo
Novo Nordisk Investigational Site, Helsinki
Novo Nordisk Investigational Site, Helsinki
Novo Nordisk Investigational Site, Turku
Novo Nordisk Investigational Site, Thriruvananthapuram
Novo Nordisk Investigational Site, Olbia
Novo Nordisk Investigational Site, Roma
Novo Nordisk Investigational Site, Chuo-ku, Tokyo
Novo Nordisk Investigational Site, Ebina-shi
Novo Nordisk Investigational Site, Imizu-shi
Novo Nordisk Investigational Site, Izumisano
Novo Nordisk Investigational Site, Koriyama-shi, Fukushima
Novo Nordisk Investigational Site, Kumamoto-shi,Kumamoto
Novo Nordisk Investigational Site, Miyazaki
Novo Nordisk Investigational Site, Naka-shi, Ibaraki
Novo Nordisk Investigational Site, Nishinomiya-shi, Hygo
Novo Nordisk Investigational Site, Ota-ku, Tokyo
Novo Nordisk Investigational Site, Ōita
Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido
Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido
Novo Nordisk Investigational Site, Sapporo-shi, Hokkaido
Novo Nordisk Investigational Site, Yokohama
Novo Nordisk Investigational Site, Bath
Novo Nordisk Investigational Site, Blackburn
Novo Nordisk Investigational Site, Carmarthen
Novo Nordisk Investigational Site, Edinburgh
Novo Nordisk Investigational Site, Leicester
Novo Nordisk Investigational Site, Manchester
Novo Nordisk Investigational Site, Middlesbrough
Novo Nordisk Investigational Site, Northampton
Novo Nordisk Investigational Site, Nottingham
Novo Nordisk Investigational Site, Penarth
Novo Nordisk Investigational Site, Plymouth
Novo Nordisk Investigational Site, Sheffield
Novo Nordisk Investigational Site, Torquay
Novo Nordisk Investigational Site, Wirral, Merseyside
Lead Sponsor
Novo Nordisk A/S
INDUSTRY